Making Money in the Psychedelics Industry Will be Harder than Cannabis
Anyone familiar with the cannabis industry knows how difficult it is to make money. Things are going to be even worse for people in the
Anyone familiar with the cannabis industry knows how difficult it is to make money. Things are going to be even worse for people in the
LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma
What You Should Know: LeanTaaS, Inc., the market leader in providing AI-powered and SaaS-based capacity management, staffing, and patient flow software for health systems, today announced